235 related articles for article (PubMed ID: 3612743)
21. Response of ligated rabbit ileal loop to Clostridium perfringens type C strains and their toxic filtrates.
Yamagishi T; Gyobu Y; Sakamoto K; Ishisaka S; Saito K; Morinaga S; Katsuda S; Umei T; Konishi K
Microbiol Immunol; 1987; 31(9):859-68. PubMed ID: 2892115
[TBL] [Abstract][Full Text] [Related]
22. Role of inducible cyclooxygenase and prostaglandins in Clostridium difficile toxin A-induced secretion and inflammation in an animal model.
Alcantara C; Stenson WF; Steiner TS; Guerrant RL
J Infect Dis; 2001 Sep; 184(5):648-52. PubMed ID: 11474431
[TBL] [Abstract][Full Text] [Related]
23. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
24. Morphologic and physiologic changes induced by Clostridium perfringens type A alpha toxin in the intestine of sheep.
Fernández Miyakawa ME; Uzal FA
Am J Vet Res; 2005 Feb; 66(2):251-5. PubMed ID: 15757123
[TBL] [Abstract][Full Text] [Related]
25. Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection.
Zhang Z; Chen X; Hernandez LD; Lipari P; Flattery A; Chen SC; Kramer S; Polishook JD; Racine F; Cape H; Kelly CP; Therien AG
Infect Immun; 2015 Jan; 83(1):405-16. PubMed ID: 25385797
[TBL] [Abstract][Full Text] [Related]
26. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
Tian JH; Fuhrmann SR; Kluepfel-Stahl S; Carman RJ; Ellingsworth L; Flyer DC
Vaccine; 2012 Jun; 30(28):4249-58. PubMed ID: 22537987
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum.
Triadafilopoulos G; Pothoulakis C; Weiss R; Giampaolo C; Lamont JT
Gastroenterology; 1989 Nov; 97(5):1186-92. PubMed ID: 2551764
[TBL] [Abstract][Full Text] [Related]
28. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon.
Mitchell TJ; Ketley JM; Haslam SC; Stephen J; Burdon DW; Candy DC; Daniel R
Gut; 1986 Jan; 27(1):78-85. PubMed ID: 3949240
[TBL] [Abstract][Full Text] [Related]
29. Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.
Koon HW; Shih DQ; Hing TC; Yoo JH; Ho S; Chen X; Kelly CP; Targan SR; Pothoulakis C
Antimicrob Agents Chemother; 2013 Jul; 57(7):3214-23. PubMed ID: 23629713
[TBL] [Abstract][Full Text] [Related]
30. Enterotoxic activity of Klebsiella oxytoca cytotoxin in rabbit intestinal loops.
Minami J; Katayama S; Matsushita O; Sakamoto H; Okabe A
Infect Immun; 1994 Jan; 62(1):172-7. PubMed ID: 8262625
[TBL] [Abstract][Full Text] [Related]
31. Yeast, beef and pork extracts counteract Clostridium difficile toxin A enterotoxicity.
Duncan PI; Fotopoulos G; Pasche E; Porta N; Masserey Elmelegy I; Sanchez-Garcia JL; Bergonzelli GE; Corthésy-Theulaz I
FEMS Microbiol Lett; 2009 Jun; 295(2):218-25. PubMed ID: 19416358
[TBL] [Abstract][Full Text] [Related]
32. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile.
Banno Y; Kobayashi T; Kono H; Watanabe K; Ueno K; Nozawa Y
Rev Infect Dis; 1984; 6 Suppl 1():S11-20. PubMed ID: 6426016
[TBL] [Abstract][Full Text] [Related]
33. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
Riegler M; Sedivy R; Pothoulakis C; Hamilton G; Zacherl J; Bischof G; Cosentini E; Feil W; Schiessel R; LaMont JT
J Clin Invest; 1995 May; 95(5):2004-11. PubMed ID: 7738167
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit.
Kelly CP; Becker S; Linevsky JK; Joshi MA; O'Keane JC; Dickey BF; LaMont JT; Pothoulakis C
J Clin Invest; 1994 Mar; 93(3):1257-65. PubMed ID: 7907603
[TBL] [Abstract][Full Text] [Related]
35. Clostridium perfringens type A enterotoxin induces tissue damage and fluid accumulation in rabbit ileum.
Sherman S; Klein E; McClane BA
J Diarrhoeal Dis Res; 1994 Sep; 12(3):200-7. PubMed ID: 7868827
[TBL] [Abstract][Full Text] [Related]
36. Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit.
Klipstein FA; Engert RF; Houghten RA
Infect Immun; 1983 Jun; 40(3):888-93. PubMed ID: 6682834
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxin and enterotoxin production by Clostridium difficile.
Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G
Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801
[TBL] [Abstract][Full Text] [Related]
38. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).
Leav BA; Blair B; Leney M; Knauber M; Reilly C; Lowy I; Gerding DN; Kelly CP; Katchar K; Baxter R; Ambrosino D; Molrine D
Vaccine; 2010 Jan; 28(4):965-9. PubMed ID: 19941990
[TBL] [Abstract][Full Text] [Related]
39. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model.
Sayeed S; Uzal FA; Fisher DJ; Saputo J; Vidal JE; Chen Y; Gupta P; Rood JI; McClane BA
Mol Microbiol; 2008 Jan; 67(1):15-30. PubMed ID: 18078439
[TBL] [Abstract][Full Text] [Related]
40. Effects of Clostridium perfringens alpha and epsilon toxins in the bovine gut.
Morris WE; Dunleavy MV; Diodati J; Berra G; Fernandez-Miyakawa ME
Anaerobe; 2012 Feb; 18(1):143-7. PubMed ID: 22178571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
